September 26, 2024
60,970
2,340
515
4.68%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
18:17Now PlayingNovo Nordisk CEO Lars Fruergaard Jørgensen was grilled by Sen. Bernie Senators about why Americans are being charged 9 times more than other countries for Wegovy and Ozempic. John Iadarola and Ana Kasparian discuss on The Young Turks. Your Support is Crucial to the Show
Get the Progressive battle plan
Watch TYT LIVE on weekdays 68 pm ET.
Read more HERE
"Novo Nordisk’s top executive faced a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the U.S.
Novo Nordisk CEO Lars Fruergaard Jørgensen did not explicitly promise lawmakers at a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., that he would slash prices for the two drugs."
***
The largest online progressive news show in the world. Hosted by Cenk Uygur and Ana Kasparian. LIVE weekdays 6-8 pm ET.
Help support our mission and get perks. Membership protects TYT's independence from corporate ownership and allows us to provide free live shows that speak truth to power for people around the world. See Perks▶
SUBSCRIBE on YOUTUBE☞
📬 Newsletters
If you want to watch more videos from TYT, consider subscribing to other channels in our network:
The Watchlist
Indisputable with Dr. Rashad Richey
Unbossed with Nina Turner
The Damage Report ▶
TYT Sports ▶
The Conversation ▶
TYT Investigates ▶
#TYT #TheYoungTurks #BreakingNews
240925__TB02_Pharma_CEO
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.